PRPO

17.3506.17%
RA

Richard Alvin Sandberg

Independent Chairman of the Board

Mr. Richard Alvin Sandberg, also known as Dick, serves as Chief Executive Officer of Resolys Bio, Inc. He is an Independent Director of Precipio, Inc (formerly known as Precipio Diagnostics, LLC) since December 3, 2019 and serves as its Chairman since March 01, 2021. He has been involved with Precipio since its inception and has acted in various advisory roles in 2019 he joined the company’s Board of Directors and has been a significant contributor to helping the company formulate strategy and execute on its plans. He had been an Independent Director at Oxford Immunotec Global PLC since 2006 until March 08, 2021. He was the Chairman of Oxford Immunotec Global PLC (Formerly Oxford Immunotec Limited since September 2008 until June 24, 2019. He is the Chairman of Oxford Immunotec Limited since October 2008. Mr. Sandberg served as the Chief Financial Officer and Vice President of Finance Division at MZT Holdings Inc. since November 2002. Mr. Sandberg served as an Assistant Secretary of MZT Holdings, Inc., since December 2003 and served as its Principal Accounting Officer. He served as Secretary of MZT Holdings, Inc., from November 2002 to December 2003 and Treasurer since November 2002. He served as Chief Financial Officer of Gen-Probe Transplant Diagnostics, Inc. from May 1997 to September 1998. He served as Chief Financial Officer and Manager of Battery Asset Management LLC. Mr. Sandberg served as Chief Executive Officer and Chief Financial Officer at private healthcare companies engaged in DNA testing and pharmaceutical development. He served as Chief Financial Officer of Critical Diagnostics Inc. He founded Dianon Systems Inc. in 1983 and served as its Chief Executive Officer and Chief Financial Officer from 1983 to 1997, a diagnostics company that was acquired in 2002 by LabCorp for 650M. He has been Chairman and Director of Jupiter Diagnostics Holding Company (Formerly Jupiter Diagnostics) since September 7, 2017. From 1997 to 2001, he served as Chairman of Tepnel Lifecodes Corporation (AKA Gen-Probe Transplant Diagnostics, Inc.). He served as Chairman of Dianon Systems Inc. from 1983 to 1997. He has been a Director of Oxford Immunotec Ltd. since 2006 and Abcodia Ltd., since November 24, 2015. He has been an Independent Director at Cylex Inc. since March 2010. He served as a Director of Ethan Allen Interiors Inc., since November 17, 2003; Critical Diagnostics Inc.; North American Scientific Inc., from August 2005 to May 12, 2009; UroMed Corp., since 1991; MZT Holdings from September 2002 to March 19, 2008; St. Lawrence Energy Corp, Prior to Reverse Merger with NOK-BONG Ship Building Co., Ltd. since 1991 and Tepnel Lifecodes Corporation and Matritech Inc. He served as a Board Member of Precipio, Inc. until June 30, 2017. He served as director from 2008 until its sale to PerkinElmer, Inc. in March 2021 also serves as a director of Poplar Healthcare, LLC, a privately owned anatomical pathology laboratory with which the Company entered into a joint venture in 2020. He also serves as Chief Executive Officer of Resolys Bio, Inc, a pharmaceutical company which is developing a treatment for long-term, chronic traumatic brain injury.

公司职务